Media coverage
8
Media coverage
Title Bristol-Myers Squibb and Vedanta Biosciences Announce a New Clinical Collaboration to Evaluate OPDIVO (Nivolumab) and VE800 in Patients with Advanced or Metastatic Cancers Media name/outlet Business Wire Country/Territory United States Date 10/12/18 Persons Jeremiah Faith Title Bristol-Myers Squibb and Vedanta Biosciences Announce a New Clinical Collaboration to Evaluate OPDIVO® (nivolumab) and VE800 in Patients with Advanced or Metastatic Cancers Media name/outlet Business Wire Country/Territory United States Date 10/12/18 Persons Jeremiah Faith Title Dec 10, 2018, 2:00 am EST Bristol-Myers Squibb and Vedanta Biosciences Announce a New Clinical Collaboration to Evaluate OPDIVO (Nivolumab) and VE800 in Patients with Advanced or Metastatic Cancers Media name/outlet The Business Journals Country/Territory United States Date 10/12/18 URL https://www.bizjournals.com/businesswire/press_releases/2018/12/10/20181209005013 Persons Jeremiah Faith Title Dec 10, 2018, 2:00 am EST Bristol-Myers Squibb and Vedanta Biosciences Announce a New Clinical Collaboration to Evaluate OPDIVO® (nivolumab) and VE800 in Patients with Advanced or Metastatic Cancers Media name/outlet The Business Journals Country/Territory United States Date 10/12/18 URL https://www.bizjournals.com/businesswire/press_releases/2018/12/10/20181209005011 Persons Jeremiah Faith Title Bristol-Myers Squibb and Vedanta Biosciences Announce a New Clinical Collaboration to Evaluate OPDIVO® (nivolumab) and VE800 in Patients with Advanced or Metastatic Cancers Media name/outlet Manchester Times Country/Territory United States Date 10/12/18 URL https://www.manchestertimes.com/news/business/bristol-myers-squibb-and-vedanta-biosciences-announce-a-new-clinical/article_4b512afb-4720-5520-82c8-649b15371d6d.html Persons Jeremiah Faith Title Bristol-Myers Squibb and Vedanta Biosciences Announce a New Clinical Collaboration to Evaluate OPDIVO® (nivolumab) and VE800 in Patients with Advanced or Metastatic Cancers Media name/outlet Herald Chronicle Country/Territory United States Date 10/12/18 URL https://www.heraldchronicle.com/news/business/bristol-myers-squibb-and-vedanta-biosciences-announce-a-new-clinical/article_007e51f7-6978-50d2-b1fd-be13870c532c.html Persons Jeremiah Faith Title Bristol-Myers Squibb and Vedanta Biosciences Announce a New Clinical Collaboration to Evaluate OPDIVO (Nivolumab) and VE800 in Patients with Advanced or Metastatic Cancers Media name/outlet Manchester Times Country/Territory United States Date 10/12/18 URL https://www.manchestertimes.com/news/business/bristol-myers-squibb-and-vedanta-biosciences-announce-a-new-clinical/article_d268e913-12f4-5e89-bcdf-5dd6c60e7984.html Persons Jeremiah Faith Title Bristol-Myers Squibb and Vedanta Biosciences Announce a New Clinical Collaboration to Evaluate OPDIVO (Nivolumab) and VE800 in Patients with Advanced or Metastatic Cancers Media name/outlet Herald Chronicle Country/Territory United States Date 10/12/18 URL https://www.heraldchronicle.com/news/business/bristol-myers-squibb-and-vedanta-biosciences-announce-a-new-clinical/article_817dfbf9-6b01-58a5-a491-4f58a0e5e297.html Persons Jeremiah Faith